Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

2LF4

Structure of a monomeric mutant of the HIV-1 capsid protein

2LF4 の概要
エントリーDOI10.2210/pdb2lf4/pdb
関連するPDBエントリー2jyl 2LF5
NMR情報BMRB: 17738
分子名称Gag polyprotein (1 entity in total)
機能のキーワードfullerene, protein transport
由来する生物種Human immunodeficiency virus 1
細胞内の位置Matrix protein p17: Virion (By similarity): Q72497
タンパク質・核酸の鎖数1
化学式量合計26643.50
構造登録者
Shin, R.S.,Tzou, Y.,Krishna, N. (登録日: 2011-06-28, 公開日: 2011-11-09, 最終更新日: 2024-05-15)
主引用文献Shin, R.,Tzou, Y.M.,Krishna, N.R.
Structure of a Monomeric Mutant of the HIV-1 Capsid Protein.
Biochemistry, 50:9457-9467, 2011
Cited by
PubMed Abstract: The capsid protein (CA) of HIV-1 plays a significant role in the assembly of the immature virion and is the critical building block of its mature capsid. Thus, there has been significant interest in the CA protein as a target in the design of inhibitors of early and late stage events in the HIV-1 replication cycle. However, because of its inherent flexibility from the interdomain linker and the monomer-dimer equilibrium in solution, the HIV-1 wild-type CA monomer has defied structural determinations by X-ray crystallography and nuclear magnetic resonance spectroscopy. Here we report the detailed solution structure of full-length HIV-1 CA using a monomeric mutant that, though noninfective, preserves many of the critical properties of the wild-type protein. The structure shows independently folded N-terminal (NTD) and C-terminal domains (CTD) joined by a flexible linker. The CTD shows some differences from that of the dimeric wild-type CTD structures. This study provides insights into the molecular mechanism of the wild-type CA dimerization critical for capsid assembly. The monomeric mutant allows investigation of interactions of CA with human cellular proteins exploited by HIV-1, directly in solution without the complications associated with the monomer-dimer equilibrium of the wild-type protein. This structure also permits the design of inhibitors directed at a novel target, viz., interdomain flexibility, as well as inhibitors that target multiple interdomain interactions critical for assembly and interactions of CA with host cellular proteins that play significant roles within the replication cycle of HIV-1.
PubMed: 21995733
DOI: 10.1021/bi2011493
主引用文献が同じPDBエントリー
実験手法
SOLUTION NMR
構造検証レポート
Validation report summary of 2lf4
検証レポート(詳細版)ダウンロードをダウンロード

250059

件を2026-03-04に公開中

PDB statisticsPDBj update infoContact PDBjnumon